Dr. June M Chan leads novel research and advances education, with the common goals of improving patient care and public health outcomes.

Dr. Chan has broad research interests in cancer prevention and public health, in particular what individuals can do to modify their risk of chronic disease, co-morbidity, and death. Her current research is focused on understanding how diet, exercise, other lifestyle factors and genetics contribute to prostate cancer progression, aggressiveness, and death. She is particularly interested in identifying modifiable lifestyle risk factors for prostate cancer progression, and using this information to better understand prostate cancer biology & inform public health recommendations. Her team's clinical and translational research studies aim to identify risk-reduction strategies for men with or at high risk for prostate cancer; evaluate novel molecular markers of prostate cancer aggressiveness that may improve screening, diagnosis, or prognosis of clinically relevant disease; and improve cancer survivorship for the millions of men living with prostate cancer worldwide. She has mentored over 40 students, post-docs, and faculty.

She is PI of a randomized clinical trial examining an exercise intervention among men pursuing active surveillance for prostate cancer; co-PI on a large Dept. of Defense Translational Impact Award focused on improving risk stratification and decision support for men considering active surveillance for low risk prostate cancer; co-leads a national web-based intervention to promote healthy diet & exercise habits among men living with prostate cancer; serves on steering committee for a global clinical trial of exercise among men with metastatic prostate cancer; and is co-investigator on a trial examining a 2 year remotely monitored blended diet and exercise intervention for men undergoing surgery for prostate cancer. She also collaborates with team members on lifestyle interventions and observational research in bladder and colorectal cancer survivors. She and her team are currently launching a new digital cohort study of cancer survivors, called Eat Move Sleep, which is focused on enrolling under-represented individuals with prostate, bladder, or colorectal cancer.

She developed the Diet & Lifestyle sub-study with the Cancer of the Prostate Strategic Research Endeavor (CaPSURE); and has collaborated broadly on other studies focused on prostate cancer, including the Health Professionals Follow-up Study, the Selenium and Vitamin E Cancer Prevention Trial (SELECT), the Prostate Cancer Active Surveillance Study (PASS), and the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group.

Prior Training:
1994 AB Applied Mathematics in Biology, Harvard College
1994-95 Fulbright Scholar, Cancer Epidemiology Unit, Uppsala University, Sweden
1998 ScD Epidemiology, Harvard School of Public Health

Research Interest Keywords:
- prostate cancer, cancer prevention, lifestyle risk factors, diet, physical activity, exercise, biomarkers, genetics, epidemiology, medical education, prognostication, public health, risk communication, health education & promotion

Teaching
- Course Director, Epid207 Epidemiologic Methods II, UCSF, Epidemiology & Biostatistics
- Steering Committee Member, PhD Program in Epidemiology and Translational Science, UCSF

- Previously (2007-2015) - Co-Director, Mechanisms, Methods, & Malignancy (M3), Essential Core Curriculum for Medical Students & Discipline Leader, Epidemiology and Evidence-Based Medicine, Essential Core Curriculum for Medical Students

University Service
- Vice Chair, Education, Epidemiology & Biostatistics UCSF
- Associate Chair, Clinical Research, Urology, UCSF
- Executive Committee Member, Department of Epidemiology & Biostatistics, UCSF
- Member, UCSF Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Leadership Committee